Clinical trial of Tumaini Ebola vaccine begins in DR Congo
By the AFREEQUE newsroom, based on Le Monde

A clinical trial of the Tumaini vaccine candidate against Ebola has begun in DR Congo, according to the World Health Organization. The vaccine targets the Bundibugyo strain, for which no vaccine has been approved, and is part of research conducted in response to the outbreak, reports Le Monde.



